The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The Renaissance of Natural Products as Drug Candidates
Abstract
Article MetricsDownloadsCitationsNo data available.051015JulAugSepOctNovDec6600Total6 Months12 MonthsTotal number of downloads for the most recent 6 whole calendar months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005) · Science · doi:10.1126/science.1109755 · Cited by 298
Njardarson, J. T., Gaul, C., Shan, D., Huang, X.-Y., & Danishefsky, S. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039714a · Cited by 166
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Anantharaman, V., Aravind, L., & Koonin, E. V. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00018-2 · Cited by 147
Cited by
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Photochemical Approaches to Complex Chemotypes: Applications in Natural Product Synthesis
Kärkäs, M. D., Porco, J. A., & Stephenson, C. R. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00760 · Cited by 1,017
Hybrid Molecules with a Dual Mode of Action: Dream or Reality?
Meunier, B. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 929
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Making carbon-nitrogen bonds in biological and chemical synthesis
Hili, R., & Yudin, A. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio0606-284 · Cited by 823
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical and Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 701
Super Atomic Clusters: Design Rules and Potential for Building Blocks of Materials
Jena, P., & Sun, Q. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00524 · Cited by 673
Drug discovery from natural sources
Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662
The pharmaceutical industry and natural products: historical status and new trends
David, B., Wolfender, J.-L., & Dias, D. A. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9367-z · Cited by 579
New aspects of natural products in drug discovery
Lam, K. S. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.04.001 · Cited by 531
Venoms as a platform for human drugs: translating toxins into therapeutics
King, G. F. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.621940 · Cited by 516
Advances in the E → Z Isomerization of Alkenes Using Small Molecule Photocatalysts
Neveselý, T., Wienhold, M., Molloy, J. J., & Gilmour, R. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00324 · Cited by 506
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & Hamann, M. T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.011 · Cited by 458
Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Taori, K., Paul, V. J., & Luesch, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7110064 · Cited by 428
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose
DeLoache, W. C., Russ, Z. N., Narcross, L., Gonzales, A. M., Martin, V. J. J., & Dueber, J. E. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1816 · Cited by 378
Plant natural products: Back to the future or into extinction?
McChesney, J. D., Venkataraman, S. K., & Henri, J. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.04.032 · Cited by 377
Natural products for human health: an historical overview of the drug discovery approaches
Bernardini, S., Tiezzi, A., Laghezza Masci, V., & Ovidi, E. (2018) · Natural Product Research · doi:10.1080/14786419.2017.1356838 · Cited by 355
Pinocembrin: A Novel Natural Compound with Versatile Pharmacological and Biological Activities
Rasul, A., Millimouno, F. M., Ali Eltayb, W., Ali, M., Li, J., & Li, X. (2013) · BioMed Research International · doi:10.1155/2013/379850 · Cited by 350
Tubulin-Interactive Natural Products as Anticancer Agents
Kingston, D. G. I. (2009) · Journal of Natural Products · doi:10.1021/np800568j · Cited by 328
Rishton, G. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.007 · Cited by 276
Recent advances in natural products from plants for treatment of liver diseases
Zhang, A., Sun, H., & Wang, X. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.062 · Cited by 276
Rocha, J., Peixe, L., Gomes, N. C. M., & Calado, R. (2011) · Marine Drugs · doi:10.3390/md9101860 · Cited by 274
Engineering Central Metabolic Pathways for High-Level Flavonoid Production in Escherichia coli
Leonard, E., Lim, K.-H., Saw, P.-N., & Koffas, M. A. G. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00200-07 · Cited by 262
Control of plant diseases by natural products: Allicin from garlic as a case study
Slusarenko, A. J., Patel, A., & Portz, D. (2008) · European Journal of Plant Pathology · doi:10.1007/s10658-007-9232-7 · Cited by 189
“” The authors go on to state that “Despite this statistic pharmaceutical companies have embraced the era of combinatorial chemistry, neglecting the development of natural products as potential drug candidates in favour of high-throughput synthesis of large compound libraries” (Peterson and Anderson 2005).”
BackgroundEthnopharmacology and Drug Discovery
Heinrich, M. (2013) · Reference Module in Chemistry, Molecular Sciences and Chemical Engineering · doi:10.1016/b978-0-12-409547-2.02773-6 · Cited by 20
Metadata
- Authors
- Paterson, I., & Anderson, E. A.
- Venue
- Science
- Published
- 2005-10-21
- Volume
- 310
- Issue
- 5747
- Pages
- 451-453
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1504523189
- Cited by
- 559
- References
- 13
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.